CETUXIMAB (C), FLUOROURACIL (F) AND CISPLATIN (P) ALONE OR WITH DOCETAXEL (D) FOR RECURRENT/METASTATIC (RM) HEAD AND NECK CANCER (HNSCC). FINAL ANALYSIS OF AIO TRIAL # 1108-CEFCID.

The requested reference [d7fac657387abba5a39700c739136277d33904f3] no longer exists in our database. It has been replaced by the current reference: [5095d2b9a9f7141a2d10b644142ce70dca0e5290]

Authors
Category Primary study
JournalANNALS OF ONCOLOGY
Year 2014
This article has no abstract
Epistemonikos ID: da1324df43dd2f525ea225b83f18e21fd12c66f6
First added on: Feb 19, 2025